NovaBay Reviews

Recommend to a friend
Approve of CEO
NovaBay Chairman, President, and CEO Ron Najafi
Ron Najafi
2 Ratings
  • Good company

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at NovaBay

    Positive Outlook
    Approves of CEO
    Positive Outlook
    Approves of CEO


    Good people, competent and fair management


    Pay is not the best

NovaBay Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Emeryville, CA
Size 16 to 50 Employees
Founded Unknown
Type Company - Public (NBY)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year

NovaBay Pharmaceuticals aims to keep the "bed bugs" away. The clinical-stage biopharmaceutical company develops antimicrobial compounds (known as Aganocide compounds) for the treatment and prevention of infections in hospital and non-hospital environments. Aganocide compounds destroy bacteria by attacking multiple sites, and aim to treat and prevent bacterial, fungal, and viral infections. The compounds are intended to prevent infections resulting from surgical or other hospital procedures, such as nasal surgery, urinary tract catheterization, and wound care, as well as... More

Work at NovaBay? Share Your Experiences


Click to Rate